These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1380937)
1. Calcitonin enhances the effects of nimodipine on biogenic amines of rat brain. Gaggi R; Chirivi L; Roncada P; Gianni AM Gen Pharmacol; 1992 May; 23(3):561-3. PubMed ID: 1380937 [TBL] [Abstract][Full Text] [Related]
2. Relationships between the effects of peripherally administered salmon calcitonin on calcaemia and brain biogenic amines. Gaggi R; De Iasio R; Gianni AM Jpn J Pharmacol; 1989 Nov; 51(3):309-20. PubMed ID: 2576081 [TBL] [Abstract][Full Text] [Related]
3. Effects of nimodipine on biogenic amines in discrete brain areas. Gaggi R; Gianni AM; Chirivi L; Roncada P Pharmacology; 1992; 44(5):237-44. PubMed ID: 1377827 [TBL] [Abstract][Full Text] [Related]
4. Comparison among the effects of nifedipine, nimodipine and nisoldipine on the brain biogenic amines of normal or haloperidol treated rats. Gaggi R; Cont R; Gianni AM Gen Pharmacol; 1993 Sep; 24(5):1091-6. PubMed ID: 8270166 [TBL] [Abstract][Full Text] [Related]
5. Actions of nimodipine on the serotonergic systems of rat brain. Gaggi R; Dall' Olio R; Santangelo M; Roncada P Gen Pharmacol; 1997 Sep; 29(3):415-9. PubMed ID: 9378249 [TBL] [Abstract][Full Text] [Related]
6. Effects of nimodipine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced depletions in the biogenic amine levels in mice. Gerlach M; Russ H; Winker J; Witzmann K; Traber J; Stasch JP; Riederer P; Przuntek H Arzneimittelforschung; 1993 Apr; 43(4):413-5. PubMed ID: 7684224 [TBL] [Abstract][Full Text] [Related]
7. Interaction between dihydropyridine calcium antagonists and morphine on the brain biogenic amines. Gaggi R; Roncada P; Gianni AM; Dall'olio R Gen Pharmacol; 1994 Sep; 25(5):923-9. PubMed ID: 7835638 [TBL] [Abstract][Full Text] [Related]
8. A physiological dose of estradiol with progesterone affects striatum biogenic amines. Morissette M; Lévesque D; Bélanger A; Di Paolo T Can J Physiol Pharmacol; 1990 Dec; 68(12):1520-6. PubMed ID: 2085798 [TBL] [Abstract][Full Text] [Related]
9. In vitro release of tritiated monoamines from rat CNS tissue by the neurotoxic compound 1-methyl-phenyl-tetrahydropyridine. Schmidt CJ; Matsuda LA; Gibb JW Eur J Pharmacol; 1984 Aug; 103(3-4):255-60. PubMed ID: 6333347 [TBL] [Abstract][Full Text] [Related]
10. LSD: effect on monoamine metabolites in rat prefrontal cortex. Bowers MB; Salomonsson LA Biochem Pharmacol; 1982 Dec; 31(24):4093-6. PubMed ID: 6186259 [No Abstract] [Full Text] [Related]
11. Regional effects of ceruletide, a cholecystokinin-8 analog, on the striatal monoaminergic systems in food-deprived mice. Yamada T; Kimura H Brain Res; 1991 Feb; 540(1-2):25-30. PubMed ID: 1711395 [TBL] [Abstract][Full Text] [Related]
12. Comparative effects of 5,6-dihydroxytryptamine and its benzo[b]-thiophene analogue on biogenic amines in the rat. Donelson AC; Bosin TR; Campaigne E; Rogers RB; Maickel RP Biochem Pharmacol; 1979 Nov; 28(22):3339-43. PubMed ID: 526340 [No Abstract] [Full Text] [Related]
13. Papaverine, drug-induced stereotypy and catalepsy and biogenic amines in the brain of the rat. Kostowski W; Gajewska S; Bidzinski A; Hauptman M Pharmacol Biochem Behav; 1976 Jul; 5(1):15-7. PubMed ID: 1033561 [TBL] [Abstract][Full Text] [Related]
14. The effect of amantadine on radiolabeled biogenic amines in the rat brain. Symchowicz S; Korduba CA; Veals J Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098 [No Abstract] [Full Text] [Related]
15. Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletors. Fuller RW; Hemrick-Luecke SK; Robertson DW Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):57-65. PubMed ID: 2417293 [TBL] [Abstract][Full Text] [Related]
16. Effects of meclofenoxate on the level and turnover of biogenic monoamines in the rat brain. Petkov VV; Grahovska T; Petkov VD; Konstantinova E Arzneimittelforschung; 1985; 35(12):1778-81. PubMed ID: 2420335 [TBL] [Abstract][Full Text] [Related]
17. Effects of the ergot alkaloid elymoclavine on the level and turnover of biogenic monoamines in the rat brain. Petkov VD; Konstantinova E Arch Int Pharmacodyn Ther; 1986 May; 281(1):22-34. PubMed ID: 2428322 [TBL] [Abstract][Full Text] [Related]
18. Effects of amphetamine on brain biogenic amines in isolated and aggregated rats. Lokiec F; Jacquot C; Rapin JR; Cohen Y Eur J Pharmacol; 1977 Aug; 44(4):391-5. PubMed ID: 891613 [TBL] [Abstract][Full Text] [Related]
19. Concentration of biogenic amines and their metabolites in different parts of brain after experimental cerebral concussion. Kmieciak-Kołada K; Felińska W; Stachura Z; Majchrzak H; Herman ZS Pol J Pharmacol Pharm; 1987; 39(1):47-53. PubMed ID: 2444951 [TBL] [Abstract][Full Text] [Related]
20. Binding of psychoactive drugs to rat brain amine receptors, measured ex vivo, and their effects on the metabolism of biogenic amines. Burki HR Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):258-66. PubMed ID: 2423886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]